Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 58.3639.8458.8548.3742.83

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 58.36 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37
Mar202042.83

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37
12.93
Mar2020 42.83 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹17,418.5 Cr 2.5% 7.7% 7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,400.0 Cr 2% -0.9% 31.9% Stock Analytics
DIVIS LABORATORIES ₹154,622.0 Cr -1.6% -0.4% 57.3% Stock Analytics
CIPLA ₹116,240.0 Cr -0.3% -2.5% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,166.0 Cr -0.5% -3.3% 14% Stock Analytics
ZYDUS LIFESCIENCES ₹98,495.2 Cr -1% 0.6% 39.1% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

2.5%

7.7%

7.5%

SENSEX

-0.4%

-2.1%

6.9%


You may also like the below Video Courses